improved clinician-reported outcomes with voxelotor in patients with scd: phase iii hope trial
Published 3 years ago • 218 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
2:12
alternative clinical outcomes for patients receiving voxelotor for scd
-
0:55
the role of clinical trials in improving treatment options for scd
-
6:57
hope for sickle cell: promising data for voxelotor
-
4:50
real-world data of voxelotor for scd
-
2:20
the evolving treatment landscape of scd
-
1:26
improving outcomes in sickle cell disease: expanding access and expediting treatment development
-
0:43
the development of a composite comorbidity index to predict car-t outcomes in patients with dlbcl
-
2:22
how hematologists can improve care for patients with sickle cell disease
-
47:13
acute sickle cell pain crisis - internal medicine residency series
-
8:09
new treatments promise sickle cell 'cure' for all ages
-
29:09
crispr tools for gene editing in the brain
-
1:59
prospective study evaluating complement activation in patients with sickle cell disease
-
2:46
optimizing care and improving quality of life in pediatric patients with sickle cell disease
-
0:42
the limited access to novel therapeutics for sickle cell disease in lmics
-
1:21
the current treatment landscape for scd
-
1:36
the limitations and future of precision medicine in sickle cell disease
-
1:48
do all patients require maintenance therapy following allosct?
-
3:59
current therapeutic management strategies in sickle cell disease
-
1:07
developing a test for sickle cell disease
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
5:16
disease-modifying and curative scd treatment updates from ascat 2023
-
3:02
the recent withdrawal of voxelotor from the market: the potential impact on patients with scd